Enzinger, C.
High-frequency MRI monitoring should be performed in natalizumab-treated MS patients with higher risk of PML - NO.
Mult Scler. 2017; 23(6):767-770
Doi: 10.1177/1352458516681505
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG